Results 21 to 30 of about 35,373 (217)

Yellow fever vaccine [PDF]

Human Vaccines & Immunotherapeutics, 2013
Yellow fever (YF) is an acute viral communicable disease transmitted by an arbovirus of the Flavivirus genus. It is primarily a zoonotic disease, especially the monkeys. Worldwide, an estimated 200,000 cases of yellow fever occurred each year, and the case-fatality rate is ~15%.
J. Erin Staples, Thomas P. Monath, Mark D. Gershman, Alan D.T. Barrett   +3 more
  +6 more sources

Basal T cell activation predicts yellow fever vaccine response independently of cytomegalovirus infection and sex-related immune variations. [PDF]

Cell Rep Med
International audienceThe live-attenuated yellow fever 17D (YF17D) vaccine is a model of acute viral infection that induces long-lasting protective immunity. Among immunocompetent adults, responses to YF17D vary significantly.
Santos-Peral A, Zaucha M, Nikolova E, Yaman E, Puzek B, Winheim E, Goresch S, Scheck MK, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Jia S, Luppa F, Pritsch M, Butt J, Metz-Zumaran C, Barba-Spaeth G, Endres S, Kim-Hellmuth S, Waterboer T, Krug AB, Rothenfusser S.   +22 more
europepmc   +2 more sources

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. [PDF]

J Bras Nefrol
Introduction: In December 2016, an outbreak of sylvatic yellow fever (YF) occurred in the non-endemic areas of the south-eastern region of Brazil. The immune response to the yellow fever vaccine and its safety in individuals with chronic kidney disease ...
Distenhreft JIQ, Couto-Lima D, Andreazzi CS, Thomazini JFRC, Vasconcellos Filho LM, Falqueto A, Luchi WM.   +6 more
europepmc   +2 more sources

Yellow fever vaccination before and during the covid-19 pandemic in Brazil

Revista de Saúde Pública, 2022
OBJECTIVE To analyze the number of yellow fever vaccine doses administered before and during the covid-19 pandemic in Brazil. METHODS This is an ecological, time series study based on data from the National Immunization Program.
Tércia Moreira Ribeiro da Silva, Ana Carolina Micheletti Gomide Nogueira de Sá, Elton Junio Sady Prates, Daiana Elias Rodrigues, Thales Philipe Rodrigues da Silva, Fernanda Penido Matozinhos, Ed Wilson Rodrigues Vieira   +6 more
doaj   +1 more source

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines

Human Vaccines & Immunotherapeutics, 2022
Despite the existence of a highly efficient yellow fever vaccine, yellow fever reemergence throughout Africa and the Americas has put 900 million people in 47 countries at risk of contracting the disease.
Gerardo Montalvo Zurbia-Flores, Christine S Rollier, Arturo Reyes-Sandoval   +2 more
doaj   +1 more source

Characterization of Yellow Fever Suspected Cases and Confirmed Outbreaks in a Southwest State, Nigeria, 2021 [PDF]

Journal of Health Sciences and Surveillance System, 2022
Background: Yellow fever (YF) is an acute viral hemorrhagic fever caused by the yellow fever virus and transmitted by Aedes mosquito species. Despite the availability of a very effective vaccine, yellow fever virus (YFV) remains a public health threat ...
Itse Olaoye, Akinola Fatiregun, Adewale M. Adejugbagbe, Modupeola Dosumu, Ekun Opeyemi, Zubairu Mahmud, David Adeleke, Tsemaye Jacdonmi, Aladesawe Adesokeji, Famokun Gboyega, Abiona Samuel   +10 more
doaj   +1 more source

Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report

BMC Infectious Diseases, 2020
Background Yellow fever vaccine exists for over 80 years and is considered to be relatively safe. However, in rare cases it can produce serious neurotropic and viscerotropic complications.
Lev Volkov, Gilda Grard, Pierre-Edouard Bollaert, Guillaume A. Durand, Aurélie Cravoisy, Marie Conrad, Lionel Nace, Guilhem Courte, Rémy Marnai, Isabelle Leparc-Goffart, Sébastien Gibot   +10 more
doaj   +1 more source

Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Molecular Therapy: Methods & Clinical Development, 2022
New platforms are needed for the design of novel prophylactic vaccines and advanced immune therapies. Live-attenuated yellow fever vaccine YF17D serves as a vector for several licensed vaccines and platform for novel candidates. On the basis of YF17D, we
Li-Hsin Li, Laurens Liesenborghs, Lanjiao Wang, Marleen Lox, Michael Bright Yakass, Sander Jansen, Ana Lucia Rosales Rosas, Xin Zhang, Hendrik Jan Thibaut, Dirk Teuwen, Johan Neyts, Leen Delang, Kai Dallmeier   +12 more
doaj   +1 more source

Malaria transmission in Africa: Its relationship with yellow fever and measles.

PLoS ONE, 2022
BackgroundMalaria has been strongly linked to the transmission and pathophysiology of some viral diseases. Malaria and vaccine-preventable diseases often co-exist in endemic countries but the implication of their co-existence on their transmission ...
Oluyemi A Okunlola, Oyetunde T Oyeyemi
doaj   +1 more source

Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021

Emerging Infectious Diseases, 2022
Ghana is a yellow fever–endemic country and experienced a vaccine-derived polio outbreak in July 2019. A reactive polio vaccination campaign was conducted in September 2019 and preventive yellow fever campaign in November 2020.
Kwame Amponsa-Achiano, Joseph Asamoah Frimpong, Danielle Barradas, Delia Akosua Bandoh, Ernest Kenu   +4 more
doaj   +1 more source